0000905148-23-001298.txt : 20231103 0000905148-23-001298.hdr.sgml : 20231103 20231103164422 ACCESSION NUMBER: 0000905148-23-001298 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231101 FILED AS OF DATE: 20231103 DATE AS OF CHANGE: 20231103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chen Yajing CENTRAL INDEX KEY: 0001985694 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38205 FILM NUMBER: 231377035 MAIL ADDRESS: STREET 1: 314 MAIN STREET STREET 2: 4TH FLOOR, SUITE 100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zai Lab Ltd CENTRAL INDEX KEY: 0001704292 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4560 JINKE ROAD STREET 2: BLDG. 1, 4F, PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 BUSINESS PHONE: 862161632588 MAIL ADDRESS: STREET 1: 4560 JINKE ROAD STREET 2: BLDG. 1, 4F, PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 4 1 form4.xml X0508 4 2023-11-01 0001704292 Zai Lab Ltd ZLAB 0001985694 Chen Yajing C/O ZAI LAB LIMITED 314 MAIN STREET, 4TH FLOOR, SUITE 100 CAMBRIDGE MA 02142 true Chief Financial Officer false American Depositary Shares 2023-11-01 4 M 0 500 A 7147 D American Depositary Shares 2023-11-02 4 S 0 165 25.23 D 6982 D Restricted Share Units 2023-11-01 4 M 0 500 0 D American Depositary Shares 500 1000 D Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. ADSs acquired on vesting of Restricted Share Units. Each ADS represents ten Ordinary Shares of the issuer. Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer. These ADSs were sold automatically to cover taxes upon vesting of Restricted Share Units. The Restricted Share Units vest in equal annual installments over four years beginning on 11/01/2022, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting. /s/ Bruce Blefeld, Attorney-in-Fact 2023-11-03